Literature DB >> 17559175

Protective capacity and epitope specificity of CD8(+) T cells responding to lethal West Nile virus infection.

James D Brien1, Jennifer L Uhrlaub, Janko Nikolich-Zugich.   

Abstract

West Nile virus (WNV) is a small, positive-strand RNA virus belonging to the Flaviviridae genus, which causes lethal encephalitis in a subset of infected birds and mammals. In humans, WNV exhibits pronounced age-related morbidity and mortality, but the basis of this effect is unclear, and the molecular and cellular parameters of the host-WNV infection are just beginning to be elucidated. Indeed, numerous mechanisms were implicated in protection in vivo against WNV (IFN-I and IFN-gamma, antibody, C', CD8 and CD4 T cells), but the individual importance of each one of these remains unclear. Here, we show that transfer of highly enriched naïve CD8(+ )T cells protects the majority of alymphoid mice against lethal WNV infection. To substantiate and expand this finding, we defined the peptide specificity of the CD8 response in H-2b mice and used a panel of identified peptides to map one dominant (NS4b (2248-2256)) and several subdominant epitopes. The hierarchy of these epitopes was stably maintained in the memory responses. Most importantly, CTL lines directed against these peptides conferred protection against lethal WNV infection in direct proportion to the epitope immunodominance. These results provide a springboard for future characterization of T cell responses against WNV and demonstrate, for the first time, that CD8 T cells can single-handedly protect from this disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17559175     DOI: 10.1002/eji.200737196

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  88 in total

1.  Sequential immunization with heterologous chimeric flaviviruses induces broad-spectrum cross-reactive CD8+ T cell responses.

Authors:  Rekha Singh; Alan L Rothman; James Potts; Farshad Guirakhoo; Francis A Ennis; Sharone Green
Journal:  J Infect Dis       Date:  2010-07-15       Impact factor: 5.226

Review 2.  Feasibility of cross-protective vaccination against flaviviruses of the Japanese encephalitis serocomplex.

Authors:  Mario Lobigs; Michael S Diamond
Journal:  Expert Rev Vaccines       Date:  2012-02       Impact factor: 5.217

Review 3.  Current trends in West Nile virus vaccine development.

Authors:  Ian J Amanna; Mark K Slifka
Journal:  Expert Rev Vaccines       Date:  2014-04-01       Impact factor: 5.217

4.  gammadelta T cells promote the maturation of dendritic cells during West Nile virus infection.

Authors:  Hao Fang; Thomas Welte; Xin Zheng; Gwong-Jen J Chang; Michael R Holbrook; Lynn Soong; Tian Wang
Journal:  FEMS Immunol Med Microbiol       Date:  2010-02-17

5.  Age-related dysregulation of CD8+ T cell memory specific for a persistent virus is independent of viral replication.

Authors:  Anna Lang; James D Brien; Ilhem Messaoudi; Janko Nikolich-Zugich
Journal:  J Immunol       Date:  2008-04-01       Impact factor: 5.422

6.  West Nile virus-specific CD4 T cells exhibit direct antiviral cytokine secretion and cytotoxicity and are sufficient for antiviral protection.

Authors:  James D Brien; Jennifer L Uhrlaub; Janko Nikolich-Zugich
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

Review 7.  West Nile virus infection and immunity.

Authors:  Mehul S Suthar; Michael S Diamond; Michael Gale
Journal:  Nat Rev Microbiol       Date:  2013-02       Impact factor: 60.633

8.  Construction and characterization of a single-cycle chimeric flavivirus vaccine candidate that protects mice against lethal challenge with dengue virus type 2.

Authors:  Ryosuke Suzuki; Evandro R Winkelmann; Peter W Mason
Journal:  J Virol       Date:  2008-12-10       Impact factor: 5.103

9.  A hydrogen peroxide-inactivated virus vaccine elicits humoral and cellular immunity and protects against lethal West Nile virus infection in aged mice.

Authors:  Amelia K Pinto; Justin M Richner; Elizabeth A Poore; Pradnya P Patil; Ian J Amanna; Mark K Slifka; Michael S Diamond
Journal:  J Virol       Date:  2012-12-05       Impact factor: 5.103

10.  The RIG-I-like receptor LGP2 controls CD8(+) T cell survival and fitness.

Authors:  Mehul S Suthar; Hilario J Ramos; Margaret M Brassil; Jason Netland; Craig P Chappell; Gabriele Blahnik; Aimee McMillan; Michael S Diamond; Edward A Clark; Michael J Bevan; Michael Gale
Journal:  Immunity       Date:  2012-07-26       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.